Back
Fortive Corp. 10K Form
Sell
35
FTV
Fortive Corp.
Last Price:
$58.27
Seasonality Move:
-5.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-25 | 10Q | FTV/Fortive Corp. Quarterly |
| 2023-07-26 | 10Q | FTV/Fortive Corp. Quarterly |
| 2023-04-26 | 10Q | FTV/Fortive Corp. Quarterly |
| 2022-10-26 | 10Q | FTV/Fortive Corp. Quarterly |
| 2022-07-28 | 10Q | FTV/Fortive Corp. Quarterly |
| 2022-04-28 | 10Q | FTV/Fortive Corp. Quarterly |
Receive FTV News And Ratings
See the #1 stock for the next 7 days that we like better than FTV
FTV Financial Statistics
Sales & Book Value
| Annual Sales: | $4.2B |
|---|---|
| Cash Flow: | $335.5M |
| Price / Cash Flow: | 19.8 |
| Annual Sales: | $20.59 |
| Price / Book: | 2.81 |
Profitability
| EPS (TTM): | 1.73140 |
|---|---|
| Net Income (TTM): | $647M |
| Gross Margin: | $2.6B |
| Return on Equity: | 7.39% |
| Return on Assets: | 4.26% |
Fortive Corp. Earnings Forecast
Key Fortive Corp. Financial Ratios
-
The Gross Profit Margin over the past 14 years for FTV is 63.50%.
-
The Selling, General & Administrative Expenses for FTV have been equal to 39.95% of Gross Profit Margin.
-
The Research & Development expenses have been 6.23% of Revenue.
-
The Interest Expense is 22.62% of Operating Income.
-
The Net Earning history of FTV is 12.81% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 8 years.
Fortive Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Machinery |
| Sector: | Industrials |
| Current Symbol: | FTV |
| CUSIP: | 34959J |
| Website: | fortive.com |
Debt
| Debt-to-Equity Ratio: | 0.5 |
|---|---|
| Current Ratio: | 0.71 |
| Quick Ratio: | 0.48 |
Price-to-Earnings
| Trailing P/E Ratio: | 33.45 |
|---|---|
| Forward P/E Ratio: | 18.2 |
FTV Technical Analysis vs Fundamental Analysis
Sell
35
Fortive Corp. (FTV)
is a Sell
Is Fortive Corp. a Buy or a Sell?
-
Fortive Corp. stock is rated a SellThe current Fortive Corp. [FTV] share price is $57.86. The Score for FTV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.